5 Key Takeaways

• 1

  Karen Yeo emphasizes the importance of pharmacokinetic modeling in addressing drug use gaps during pregnancy.

• 2

  Pregnant women are often excluded from clinical trials, leading to limited data for informed treatment decisions.

• 3

  Physiological changes during pregnancy significantly affect drug metabolism, necessitating tailored dosing guidelines.

• 4

  Physiologically based pharmacokinetic modeling can identify data gaps and foster collaboration for better drug research.

• 5

  Improving communication and evidence availability is crucial for encouraging pregnant women to participate in clinical research.